Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 320

1.

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.

Myers RP, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Levstik M, Duarte-Rojo A, Wong D, Crotty P, Elkashab M.

Liver Int. 2012 Jul;32(6):902-10. doi: 10.1111/j.1478-3231.2012.02781.x. Epub 2012 Mar 21.

PMID:
22435761
2.

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.

de Lédinghen V, Vergniol J, Foucher J, Merrouche W, le Bail B.

Liver Int. 2012 Jul;32(6):911-8. doi: 10.1111/j.1478-3231.2012.02820.x.

PMID:
22672642
3.

Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.

Chan WK, Nik Mustapha NR, Mahadeva S.

J Gastroenterol Hepatol. 2014;29(7):1470-6. doi: 10.1111/jgh.12557.

PMID:
24548002
4.

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients.

Shen F, Zheng RD, Mi YQ, Wang XY, Pan Q, Chen GY, Cao HX, Chen ML, Xu L, Chen JN, Cao Y, Zhang RN, Xu LM, Fan JG.

World J Gastroenterol. 2014 Apr 28;20(16):4702-11. doi: 10.3748/wjg.v20.i16.4702.

5.

How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.

Carvalhana S, Leitão J, Alves AC, Bourbon M, Cortez-Pinto H.

Liver Int. 2014 Jul;34(6):e111-7. doi: 10.1111/liv.12305. Epub 2013 Sep 4.

PMID:
24034415
6.

Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.

Chon YE, Jung KS, Kim SU, Park JY, Park YN, Kim DY, Ahn SH, Chon CY, Lee HW, Park Y, Han KH.

Liver Int. 2014 Jan;34(1):102-9. doi: 10.1111/liv.12282. Epub 2013 Sep 13.

PMID:
24028214
7.

Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.

de Lédinghen V, Wong GL, Vergniol J, Chan HL, Hiriart JB, Chan AW, Chermak F, Choi PC, Foucher J, Chan CK, Merrouche W, Chim AM, Le Bail B, Wong VW.

J Gastroenterol Hepatol. 2016 Apr;31(4):848-55. doi: 10.1111/jgh.13219.

PMID:
26514665
8.

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.

Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y, Ono M, Eguchi Y, Inoue T, Yamanaka T, Wada K, Saito S, Nakajima A.

Gastroenterology. 2016 Mar;150(3):626-637.e7. doi: 10.1053/j.gastro.2015.11.048. Epub 2015 Dec 8.

9.

Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease.

Shen F, Zheng RD, Shi JP, Mi YQ, Chen GF, Hu X, Liu YG, Wang XY, Pan Q, Chen GY, Chen JN, Xu L, Zhang RN, Xu LM, Fan JG.

Liver Int. 2015 Nov;35(11):2392-400. doi: 10.1111/liv.12809. Epub 2015 Mar 6.

10.

Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B.

Mi YQ, Shi QY, Xu L, Shi RF, Liu YG, Li P, Shen F, Lu W, Fan JG.

Dig Dis Sci. 2015 Jan;60(1):243-51. doi: 10.1007/s10620-014-3341-x. Epub 2014 Sep 7.

PMID:
25194851
11.

Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study.

Lupșor-Platon M, Feier D, Stefănescu H, Tamas A, Botan E, Sparchez Z, Maniu A, Badea R.

J Gastrointestin Liver Dis. 2015 Mar;24(1):35-42. doi: 10.15403/jgld.2014.1121.mlp.

12.

Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B.

Cardoso AC, Beaugrand M, de Ledinghen V, Douvin C, Poupon R, Trinchet JC, Ziol M, Bedossa P, Marcellin P.

Ann Hepatol. 2015 Nov-Dec;14(6):826-36. doi: 10.5604/16652681.1171762.

PMID:
26436354
13.

Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study.

Myers RP, Elkashab M, Ma M, Crotty P, Pomier-Layrargues G.

Can J Gastroenterol. 2010 Nov;24(11):661-70.

14.

Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B.

Wang CY, Lu W, Hu DS, Wang GD, Cheng XJ.

World J Gastroenterol. 2014 Aug 14;20(30):10585-90. doi: 10.3748/wjg.v20.i30.10585.

15.

Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy.

Karlas T, Petroff D, Garnov N, Böhm S, Tenckhoff H, Wittekind C, Wiese M, Schiefke I, Linder N, Schaudinn A, Busse H, Kahn T, Mössner J, Berg T, Tröltzsch M, Keim V, Wiegand J.

PLoS One. 2014 Mar 17;9(3):e91987. doi: 10.1371/journal.pone.0091987. eCollection 2014.

16.

Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy.

Yilmaz Y, Yesil A, Gerin F, Ergelen R, Akin H, Celikel ÇA, Imeryuz N.

Scand J Gastroenterol. 2014 May;49(5):611-6. doi: 10.3109/00365521.2014.881548. Epub 2014 Mar 11.

PMID:
24611771
17.

Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis.

Lupsor M, Badea R, Stefanescu H, Grigorescu M, Serban A, Radu C, Crişan D, Sparchez Z, Iancu S, Maniu A.

J Gastrointestin Liver Dis. 2010 Mar;19(1):53-60.

18.

[A multi-center clinical study of a novel controlled attenuation parameter for assessment of fatty liver].

Shen F, Zheng R, Mi Y, Shi J, Chen G, Chen J, Xu L, Pan Q, Xu L, Fan J.

Zhonghua Gan Zang Bing Za Zhi. 2014 Dec;22(12):926-31. doi: 10.3760/cma.j.issn.1007-3418.2014.12.010. Chinese.

PMID:
25654287
19.

Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques.

Karlas T, Berger J, Garnov N, Lindner F, Busse H, Linder N, Schaudinn A, Relke B, Chakaroun R, Tröltzsch M, Wiegand J, Keim V.

World J Gastroenterol. 2015 Apr 28;21(16):4894-902. doi: 10.3748/wjg.v21.i16.4894.

20.

Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis.

Ferraioli G, Tinelli C, Lissandrin R, Zicchetti M, Dal Bello B, Filice G, Filice C.

World J Gastroenterol. 2014 Jun 7;20(21):6626-31. doi: 10.3748/wjg.v20.i21.6626.

Supplemental Content

Support Center